[Features of diagnosis and treatment of fatty pancreatic necrosis].

The article deals with clinical experience in early diagnosis of pancreatonecrosis in which enzymological methods of examination acquire importance. The most informative test in the diagnosis of fatty pancreatonecrosis is the increase of the pancreatic lipase content in blood serum, particularly in stimulation of pancreatic secretion by pancreozymin. A new Soviet-produced peptide agent--dalargin was included in the complex drug treatment of fatty pancreatonecrosis in 74 patients.

[Treatment of non-healing wounds and trophic ulcers by low- intensity laser irradiation in an outpatient clinic].

Experience in treating 351 patients with persistent wounds and trophic ulcers by low-intensity laser radiation in out-patient clinics is generalized. Complete epithelialization of the wound or ulcer surface occurred in 236 patients. There were 246 patients aged 60, all were treated without leave from work.

[Treatment of peptic ulcer hemorrhage with leucine enkephalin analog dalargin].

The article discusses treatment of 72 patients suffering from duodenal ulcer complicated by bleeding with the Soviet-made preparation Dalargin which is a synthetic analogue of leucine-enkephalin. The preparation was infused intravenously in a dose of 3 mg in physiological solution once daily. No other additional antiulcerative agents were give.

[Differential diagnosis of cavitary formations in the lungs of tuberculous and nontuberculous etiology].

In a group of 155 patients examined, 75 (48.2%) subjects were proved to have tuberculous cavities; 80 (51.8%), non-tuberculous cavities; 60, abscess and 20, cancer.

[Plasmapheresis in the treatment of critical stages of ischemia in diabetic angiopathy of the lower extremities].

The authors have used gravitation plasmapheresis in the treatment of 26 patients with diabetic angiopathies of lower extremities. It was established that continuous gravitation plasmapheresis facilitated the immediate correction of most of the altered biochemical and coagulation parameters of blood, in patients with diabetes mellitus. The use of rheopolyglucinum is followed by stable central hemodynamics and stabilization of the general state of the patients during continuous plasmapheresis which allows to recommend rheopolyglucinum as the main plasma-substituting solution for fractionation of blood in patients with diabetic angiopathies.